During the treatment you may experience sensations of pulling, tugging, mild pinching, cold, and tingling at the treatment site
In the ACHIEVE-1 study, a 36 mg dose resulted in a reduction in HbA1c of 1.31.6% from a baseline of 8.0%, and an average weight loss of 7.9% (approximately 16.0 lbs) over 40 weeks
Serious adverse effects are uncommon when dosing is appropriate and therapy is supervised, but ongoing monitoring and periodic labs are recommended to watch for shifts in glucose, fluid balance, or hormone sensitivity
This publication has not independently audited or verified the source, methodology, or freshness of this rating
Track trends over weeks, not days
This helps lower blood sugar levels and prevent hyperglycemia, a hallmark of diabetes